Early Universal Screening with a Combination of Fasting Plasma Glucose and Glycated Haemoglobin is the Best Community Screening Strategy for Dysglycaemia in Indian Youth

早期普遍筛查,结合空腹血糖和糖化血红蛋白检测,是印度青少年血糖异常的最佳社区筛查策略。

阅读:1

Abstract

INTRODUCTION: Any intervention to reduce the incidence of diabetes needs to target the young population at the stage of early insulin resistance or prediabetes. There are no screening guidelines for dysglycaemia in non-obese youth. This study was designed to find the best screening investigation for dysglycaemia in community-dwelling youth. METHODS: Using multistage sampling, community-dwelling non-obese subjects aged 18-30 years were assessed for diabetes using a 75 g oral glucose tolerance test [OGTT], fasting plasma glucose [FPG] and glycated haemoglobin (HbA1c) at a health facility near the participants' home. Diagnosis of dysglycaemia (diabetes and prediabetes) was made based on the American Diabetes Association (ADA) criteria. RESULTS: A total of 2540 participants from 74 family welfare centres with a mean age of 24.2 ± 3.5 years and 1292 female (50.8%) participants were included. Urban, rural, coastal and hilly regions contributed 661 (26%), 580 (22.8%), 656 (25.8%) and 643 (25.3%) participants, respectively, and 88.4% of participants came from the middle or lower middle class. Diabetes was detected in 59 (2.3%) and prediabetes in 568 (22.4%) of these young participants. The sensitivity of HbA1c with FPG in diagnosing diabetes mellitus (DM) and prediabetes was 87.87%, whereas the sensitivity of FPG and 2-h OGTT together was 44.2% (P < 0.001). CONCLUSION: The prevalence of dysglycaemia in non-obese Indian youth is alarmingly high. There is an urgent need to define screening strategies for dysglycaemia in this population. Based on this study, universal screening for dysglycaemia using HbA1c and FPG in early adulthood is recommended.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。